Aware of the problems caused by the annual change in prices to the entire drug supply chain, Logifarma has decided to improve its labelling capacity for its clients. New equipment has been purchased, thus guaranteeing the drug supply and preventing out-of-stock situations.
The acquisition of the new labelling line (4th line) has led to a 25% increase in the labelling capacity. At the moment, approximately 120,000 labels can be produced a day.
By doing so, Logifarma believes that it has responded to its clients’ expectations, by mitigating the impact that price changes have on the drug chain, preventing lack of supply and protecting public health.
“The legal framework and increase in price changes have led Logifarma to strategically invest in new specialised labelling equipment with the aim of making processes automatic and more flexible, as well as increasing revenue from these operations by means of an increased installed capacity. At the moment, MSD sees in Logifarma a business partner that distinguishes itself mainly by its response capacity, even in periods of high demand from all its clients. High quality standards and excellent service are always guaranteed.”
Statement by Cecília André – Demand Planning Manager MSD; Senior Specialist